Wealthcare Advisory Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-998
Closed -$202K – 770
2023
Q1
$202K Buy
+998
New +$160K 0.01% 688
2021
Q2
– Sell
-72
Closed -$10K – 1991
2021
Q1
$10K Buy
+72
New +$11.6K ﹤0.01% 1466
2020
Q2
– Sell
-36
Closed -$4K – 1439
2020
Q1
$4K Hold
36
– – ﹤0.01% 1192
2019
Q4
$4K Hold
36
– – ﹤0.01% 1174
2019
Q3
$3K Hold
36
– – ﹤0.01% 1181
2019
Q2
$2K Buy
+36
New +$2.52K ﹤0.01% 1214

Other funds holding SGEN

Wealthcare Advisory Partners's SGEN Position: Q2 2023 in Review

Wealthcare Advisory Partners sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 998 shares — an estimated $202K sold.

Wealthcare Advisory Partners first reported a position in SGEN in Q2 2019 and held it in 6 quarters. The position peaked at $202K in Q1 2023. 594 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

  • Wealthcare Advisory Partners reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 998 Seagen Inc. Common Stock shares in Q2 2023, an estimated $202K.
  • Wealthcare Advisory Partners first reported a position in Seagen Inc. Common Stock in Q2 2019 and held it in 6 quarters.
  • Wealthcare Advisory Partners's Seagen Inc. Common Stock position peaked at $202K in Q1 2023.
  • 594 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2023, filed 17 Jul 2023.